HIGHLIGHTS
- who: Yuanyuan Zhou and collaborators from the School of Biomedical Engineering, Yat-sen University, Guangzhou, China have published the Article: The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of Lumican, in the Journal: (JOURNAL) of 26/Oct/2022
- what: The aim of this study was to evaluate the anticancer activity of compound 91b1 in vitro and in vivo and screen out its regulated target. The findings of this study provide more proof of the protumorigenic effect of Lumican and the potential of quinoline compounds as antitumor agents.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.